Grivix

Grivix is a topical dermatological preparation that contains the antihistamine dimetindene maleate as its active ingredient. Formulated for external use, the product is supplied without a listed strength, reflecting its classification as a skin‑applied agent. Dimetindene maleate belongs to the H1‑receptor antagonist class and is marketed in the European Union for relief of itching and allergic skin reactions. Grivix is intended for short‑term symptom management.

Grivix is indicated for the topical treatment of various pruritic and allergic skin conditions, including both chronic and acute presentations. - Relief of itching (pruritus) associated with atopic dermatitis. - Management of allergic skin reactions such as contact dermatitis. - Symptomatic treatment of insect bite or sting reactions. - Adjunctive therapy for mild to moderate eczema flare‑ups. - Reduction of itching caused by other dermatological irritants. - Supportive care for skin irritation after exposure to chemicals or detergents. - Temporary relief of itching due to minor burns or sunburn.

Topical application of dimetindene maleate may be associated with local skin reactions and, rarely, systemic adverse effects that are generally mild and reversible.

Common: - Mild skin irritation or burning at the application site. - Transient redness or erythema. - Slight itching or pruritus worsening. - Dryness or peeling of the treated skin. - Localized swelling or edema. - Sensation of tingling or numbness.

Serious: - Allergic contact dermatitis with swelling and vesicle formation. - Severe urticaria or widespread rash. - Systemic hypersensitivity reactions such as angioedema. - Unexpected dizziness or headache (unlikely but reported). - Development of photosensitivity reactions. - Signs of systemic toxicity such as tachycardia. - Temporary discoloration or hyperpigmentation of the skin.

When using Grivix, certain precautions should be observed to minimize risk and ensure appropriate use. - Avoid applying to broken, inflamed, or infected skin unless directed by a healthcare professional. - Do not use on mucous membranes, eyes, or genital areas. - Limit the amount applied; excessive use may increase systemic absorption. - Discontinue use and seek medical advice if a rash or worsening irritation develops. - Keep the product out of reach of children; accidental ingestion can be harmful. - Consult a physician before use during pregnancy or breastfeeding, as safety data are limited. - Store at room temperature away from direct sunlight and moisture.

Dimetindene maleate may interact with other topical agents or systemic medications that affect histamine pathways or skin absorption.

Avoid: - Concurrent use with other H1‑antihistamine creams or gels, which may increase the risk of systemic antihistamine effects. - Application together with strong corticosteroid preparations on the same area, as this can alter drug penetration and efficacy.

Use with caution: - Use with occlusive dressings; they can enhance absorption and raise systemic exposure. - Combine with systemic antihistamines; monitor for additive sedation or anticholinergic effects. - Apply alongside other dermatological agents (e.g., topical antibiotics) only after evaluating for potential irritation.